Sound Wave Innovation

Sound Wave Innovation Co., Ltd. (SWI) is a Tokyo-based healthtech/biotech company developing a minimally invasive therapeutic platform using Low-Intensity Pulsed Ultrasound (LIPUS) technology, with its flagship device LIPUS-Brain designed to treat early-stage Alzheimer's disease via transcranial ultrasound stimulation. The device, designated Japan's first "Breakthrough Medical Device" for Alzheimer's treatment in 2022, aims to improve cerebral microvascular function and stimulate regenerative mechanisms without surgery or anesthesia, and is currently in a pivotal clinical trial expected to conclude by end-2026.